Correo: bd@sidmexinovia.com
Teléfono: +918866862020
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Inicio >
Survanta 8ml Injection
Survanta 8ml Injection
Manufacturer/Marketed By : Abbott
$198.00 $189.00
Survanta 8 ml (Beractant 200 mg Injection) is a pulmonary surfactant medicine used to prevent and treat Respiratory Distress Syndrome (RDS) in premature newborns with a birth weight of 700...
Collapsible text is perfect for longer content like paragraphs and descriptions. It's a great way to give people more information while keeping your layout clean. Link your text to anything, including an external website or a different page. You can set your text box to expand and collapse when people click, so they can read more or less info.
Beractant
Active Pharmaceutical Ingredient
Survanta 8ml Injection
198,00 US$
189,00 US$
Survanta 8 ml (Beractant 200 mg Injection) is a pulmonary surfactant medicine used to prevent and treat Respiratory Distress Syndrome (RDS) in premature newborns with a birth weight of 700 g or more. Extracted from bovine lungs, Beractant helps newborns’ lungs function properly by reducing surface tension and improving breathing efficiency. Survanta Injection is vital for preterm infants—especially those born before 32 weeks—who are at high risk of RDS and require endotracheal intubation for stabilization. Manufactured under strict quality standards, this medication supports neonatal respiratory care in critical situations. Parents and healthcare professionals should use it only under medical supervision. Common side effects may include noisy breathing, feeding difficulties, or mild bleeding around the endotracheal tube. Always consult a qualified neonatologist before use and report any signs of allergy or adverse reaction to Beractant.
Active Pharmaceutical Ingredient
Beractant
Usos
Prevention and treatment of Respiratory Distress Syndrome (RDS) in premature infants with a birth weight of 700 g or more. Helps reduce surface tension in the lungs, allowing easier breathing and improved oxygen exchange. Supports lung function in preterm newborns, especially those born before 32 weeks of gestation. Used in neonatal intensive care units (NICUs) as part of respiratory support for infants requiring endotracheal intubation and mechanical ventilation. Plays a crucial role in stabilizing critically ill premature babies at high risk of developing RDS. Aids in reducing the need for prolonged respiratory support and improving overall survival rates in neonates.
Beneficios
Restores normal lung function: Replaces the missing or inactive surfactant in premature infants’ lungs, enabling proper breathing. Prevents and treats Respiratory Distress Syndrome (RDS): Reduces the severity and complications of RDS in preterm newborns. Improves oxygenation and ventilation: Enhances gas exchange and lung compliance, supporting effective respiration. Reduces the need for mechanical ventilation: Helps stabilize infants faster, potentially shortening NICU stay and ventilation time. Clinically proven and safe: Manufactured under stringent quality standards and widely used in neonatal care worldwide. Supports early survival and recovery: Improves the overall outcome of premature infants, promoting healthier development during the critical early stage.
Efectos secundarios
As with all medicines, Servant Injection 150 mg may cause side effects which do not require medical attention and which will disappear as your body adjusts to the medicine. If they persist or you're concerned about them, tell your doctor.
Efectos secundarios más comunes
Noisy or irregular breathing after administration
Mild bleeding or discharge around the endotracheal tube
Feeding difficulties or reflux
Temporary slowing of heart rate (bradycardia)
Oxygen desaturation (brief drop in oxygen levels)
Efectos secundarios comunes
Lung infection (pneumonia)
Pulmonary hemorrhage (bleeding in the lungs)
Blockage of the breathing tube (endotracheal obstruction)
Allergic reaction to Beractant (rash, swelling, difficulty breathing)
Cómo utilizar
Survanta is administered only by trained healthcare professionals in a hospital or neonatal intensive care setting. The medication is given directly into the lungs through an endotracheal tube after the infant has been intubated and stabilized. The dose and timing depend on the newborn’s weight, gestational age, and respiratory condition. It may be used as a preventive dose shortly after birth in high-risk preterm infants, or as a rescue treatment for those already showing signs of Respiratory Distress Syndrome (RDS). During and after administration, the infant’s breathing, heart rate, and oxygen levels are closely monitored by the medical team. Repeated doses may be given if symptoms persist, always under strict neonatal supervision.
Consejos de seguridad
Survanta should be administered only under the supervision of a qualified neonatologist or healthcare professional experienced in managing premature infants with Respiratory Distress Syndrome (RDS). It must be used strictly within a hospital or neonatal intensive care unit (NICU) equipped for endotracheal intubation and continuous monitoring. Careful observation of the infant’s heart rate, oxygen saturation, and lung function is essential during and after administration. The product should not be shaken or diluted, and any unused portion should be discarded immediately after use. Parents and caregivers should be informed that Survanta is not for home use and should never be self-administered. Report any signs of allergic reaction, persistent breathing difficulty, or unusual skin discoloration to the attending physician promptly. Proper handling, storage (as per label instructions), and disposal protocols must be followed to maintain product safety and sterility.
Descargo de responsabilidad
Sidmex Inovia se esfuerza por brindar información precisa y confiable; sin embargo, todo el contenido de este sitio web, incluidas las descripciones y composiciones de los productos, tiene fines meramente informativos y no debe considerarse un sustituto del consejo, diagnóstico o tratamiento médico profesional.
Se recomienda a los usuarios consultar con un profesional de la salud calificado antes de tomar cualquier decisión médica. La información proporcionada no debe utilizarse para el autodiagnóstico ni la automedicación.
Todos los productos listados están destinados exclusivamente a fines comerciales y consultas al por mayor. Sidmex Inovia no promueve el uso directo por parte del consumidor y su objetivo es apoyar, no reemplazar, la relación entre el profesional de la salud y el paciente.
Los nombres de productos, marcas registradas y marcas comerciales pertenecen a sus respectivos propietarios, y su uso no implica ninguna afiliación ni respaldo. Sidmex Inovia no se responsabiliza por las consecuencias derivadas del uso de la información proporcionada en este sitio web.